Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase 4 1Phase 1/2 1

Status

Unknown 22Completed 4Not yet recruiting 2Recruiting 1

Sponsor Class

OTHER 3INDUSTRY 1

Study Type

Interventional 4

Sponsor

Cancer Type

Thoracic 4Other solid neoplasm 2Sarcoma 1Gynecologic 1Gastrointestinal 1CNS 1Breast 1

Conditions

Carcinoma, Non-Small-Cell Lung 4

Interventions

Carboplatin 463Cisplatin 379Paclitaxel 313Pemetrexed 300Docetaxel 242Erlotinib Hydrochloride 240Gemcitabine 232pembrolizumab 173Radiotherapy 172Bevacizumab 169Nivolumab 130Etoposide 106Gefitinib 95Vinorelbine 84durvalumab 71atezolizumab 68Cetuximab 65Topotecan 61Drug Therapy 57Ipilimumab 55Irinotecan 54osimertinib 53Radiosurgery 52Afatinib 51Surveys and Questionnaires 38130-nm albumin-bound paclitaxel 38Albumin-Bound Paclitaxel 37Taxes 35Cyclophosphamide 35Surgical Procedures, Operative 34

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Completed × Endostatins × Thoracic × Clear all
NCT01733589 2017-07-14

Recombinant Human Endostatin Continued Pumping Into Vein Combining With CCRT in Unresectable Stage III NSCLC

Zhejiang Cancer Hospital

Phase 1/2 Completed
73 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT03117335 2017-04-17

Recombinant Endostatin Combined With Vinorelbine and Cisplatin in Patients With Advanced Non-small Cell Lung Cancer

Jiangsu Wuzhong Pharmaceutical Group Co., Ltd.

Phase 3 Completed
560 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT02497118 2015-07-14

Recombinant Human Endostatin Combined With NP in Neoadjuvant Chemotherapy of Stage â…¢A NSCLC

Tianjin Medical University Cancer Institute and Hospital

Phase 4 Completed
30 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT01124253 2010-05-17

Dengshan

Shanghai Jiao Tong University School of Medicine

Phase 3 Completed
250 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon âš¡